Vestal Point Capital, LP Ptc Therapeutics, Inc. Call Options Transaction History
Vestal Point Capital, LP
- $1.34 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PTCT
# of Institutions
221Shares Held
79.3MCall Options Held
122KPut Options Held
207K-
Vanguard Group Inc Valley Forge, PA8.97MShares$362 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$332 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$314 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$299 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$281 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $2.89B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...